Ziccum AB appointed a Scientific Director, as part of a major reorganization aiming to facilitate and accelerate its new strategic focus on key projects and vaccine platforms. Ziccum Senior Formulation Specialist Fabrice Rose will assume the new role. The reorganization was implemented on August 1, 2022.Ziccum AB has appointed Fabrice Rose, until recently its Senior Formulation Specialist, as its new Scientific Director. Fabrice Rose is the author or co author of 16 peer-reviewed publications on vaccine formulation.

His 20 years' plus experience in formulation and drug delivery includes ten year's lab work specializing in the design and characterization of nanoparticulate vaccine formulations and investigating the physical stability of protein antigens.